Zobrazeno 1 - 10
of 215
pro vyhledávání: '"W, Olanow"'
Neuroscience Perspectives provides multidisciplinary reviews of topics in one of the most divers and rapidly advancing fields in the life sciences. Whether you are a new recruit to neuroscience, or an established expert, look to this series for'one-s
Autor:
Eduard Tolosa, Glenda M. Halliday, Connie Marras, Joseph Jankovic, John C. Rothwell, David G. Standaert, David J. Brooks, J. W. Langston, Mark Hallett, Hagai Bergman, Günther Deuschl, W. Poewe, A. J. Stoessl, Kenneth Marek, Caroline M. Tanner, Christine Klein, Anthony E. Lang, Paolo Calabresi, Mahlon R. DeLong, Dalton James Surmeier, Anthony H.V. Schapira, Jose A. Obeso, David J. Burn, Daniela Berg, Maria Stamelou, Erwan Bezard, Christopher G. Goetz, Stanley Fahn, Serge Przedborski, C. W. Olanow, Andres M. Lozano, V. Bonifati, Stéphane Lehéricy, Mayela Rodríguez-Violante, Ronald B. Postuma, G. W. Ross, Jeffrey H. Kordower, Daniel Weintraub
Publikováno v:
Movement Disorders. 32:1264-1310
This article reviews and summarizes 200 years of Parkinson's disease. It comprises a relevant history of Dr. James Parkinson's himself and what he described accurately and what he missed from today's perspective. Parkinson's disease today is understo
Autor:
Werner Poewe, S. Leibman Barak, T. Yardeni, Fabrizio Stocchi, O. Rosenfeld, C. W. Olanow, Liat Adar, O. Rascol
Publikováno v:
Parkinsonism & Related Disorders. 79:e53
Publikováno v:
Experimental neurology. 298
The development of a neuroprotective or disease-modifying therapy is the major unmet need in the management of Parkinson's Disease (PD) and the goal of much clinical and scientific research. However, despite enormous efforts and expense, no disease-m
Autor:
Lance A. Smith, C. W. Olanow, Sarah Rose, Dieter Scheller, Michael J. Jackson, Mahmoud M. Iravani, Kayhan A. Tayarani-Binazir, K. Stockwell, Peter Jenner
Publikováno v:
Experimental Neurology. 219:533-542
Rotigotine is a novel, non-ergoline dopamine D(3)/D(2)/D(1)-receptor agonist for the treatment of Parkinson's disease that can be continuously delivered by the transdermal route to provide stable plasma levels. Continuous drug delivery should reduce
Autor:
Adrian J. Williams, Richard G. Brown, Martin Rabey, Paolo Barone, Fabrizio Stocchi, S. Tluk, David B. Rye, Per Odin, Anthony H.V. Schapira, Vandana Dhawan, Kapil D. Sethi, A Forbes, W. C. Koller, Pablo Martinez-Martin, Doug MacMahon, Linda Kelly, Graeme Macphee, Kallol Ray Chaudhuri, A Bowron, C. W. Olanow, Sue Thomas, William G. Ondo
Publikováno v:
Movement Disorders. 21:916-923
Nonmotor symptoms (NMS) of Parkinson's disease (PD) are not well recognized in clinical practice, either in primary or in secondary care, and are frequently missed during routine consultations. There is no single instrument (questionnaire or scale) t
Autor:
R. D. Field, C. W. Olanow, Ray L. Watts, J. W. Langston, Caroline M. Tanner, Samuel M. Goldman
Publikováno v:
Neurology. 65:1430-1435
Background: Few occupational risk factors for Parkinson disease (PD) have been identified. Healthcare, teaching, and farming have been associated with increased risk, while welding has been proposed to accelerate age at PD onset. The aim of the prese
Autor:
Marek K, Caroline M. Tanner, C. W. Olanow, David Oakes, Karl Kieburtz, Alice Rudolph, Ira Shoulson, Anthony E. Lang, Stanley Fahn
Publikováno v:
New England Journal of Medicine. 351:2498-2508
background Despite the known benefit of levodopa in reducing the symptoms of Parkinson’s disease, concern has been expressed that its use might hasten neurodegeneration. This study assessed the effect of levodopa on the rate of progression of Parki
Autor:
T. Sreenath, Ruth H. Walker, C. W. Olanow, Donald J. Weisz, Ioanna A. Armata, P. Shashidharan, Daniela Sandu, Mitchell F. Brin, U. Potla, Kevin St. P. McNaught
Publikováno v:
Human Molecular Genetics. 14:125-133
Early-onset dystonia is an autosomal dominant movement disorder associated with deletion of a glutamic acid residue in torsinA. We generated four independent lines of transgenic mice by overexpressing human DeltaE-torsinA using a neuron specific enol
Publikováno v:
Journal of Neural Transmission. 111:1333-1341
Although improved cognition has been reported in patients with mild Parkinson's disease (PD) following the administration of levodopa, mixed results have been found in moderately-to-severely affected PD patients (MSPD), particularly in studies conduc